Results 31 to 40 of about 2,939 (191)
Nomenclature of drug-induced pityriasis rosea-like rashes [PDF]
Neuropsychiatric Disease and Treatment, 2015 Antonio AT Chuh1Prince of Wales Hospital, Hospital Authority, 2The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Shatin, Hong KongI read with admiration an article published in your ...
Chuh AAT
doaj +1 more source
Dermatology Practical & Conceptual, 2016 Background: Pityriasis rosea is a papulosquamous disease. It may occur during pregnancy; in this setting, it has occasionally been associated with adverse outcomes. Purpose: A woman who developed pityriasis rosea at the beginning of her eighth week of
Tiffany Y. Loh, Philip R. Cohen
doaj +1 more source
Pityriasis Rosea After Pfizer-BioNTech Covid-19 Vaccine: A Case Report
Turkish Journal of Internal Medicine, 2022 After the pandemic started, vaccines against SARS-CoV-2 were developed and applied in a short time. Later, various side effects were reported during the use of these vaccines.
Şeyma Handan Akyön, Yeşer Genç
doaj +1 more source
RE: Pediatric pityriasis rosea [PDF]
, 2017 We are most grateful to Drago et al. for their interest in our paper entitled “Pityriasis rosea: a natural history of pediatric cases in the Central Anatolia Region of Turkey”.
Öztürk, Pınar +5 more
core +1 more source
PITYRIASIS ROSEA MIMICKING POLYMORPHIC ERUPTIONS OF PREGNANCY [PDF]
, 2017 Pityriasis Rosea is a self-limiting skin disorder of unknown etiology affecting women more than men. It is very rare in pregnancy and evidence shows conflicting reports on pregnancy outcomes related to Pityriasis Rosea.
Balaji Ommurugan +2 more
core +4 more sources
Effectiveness of acyclovir in the treatment of pityriasis rosea. A systematic review and meta-analysis [PDF]
Anais Brasileiros de Dermatologia, 2018 : Background: There is a lack of evidence to support acyclovir administration in pityriasis rosea. Objective: To determine the efficacy of acyclovir in patients with typical pityriasis rosea.
Milton Rodriguez-Zuniga +2 more
doaj +1 more source
Pityriasis following COVID-19 vaccinations: a systematic review
Dermatology Reports, 2023 In the wake of a global COVID-19 pandemic, where innovations in vaccination technology and the speed of development and distribution have been unprecedented, a wide variety of post-vaccination cutaneous reactions have surfaced.
Laura Duzett +4 more
doaj +1 more source
Pityriasis Rosea Variant: Persistent Pityriasis Rosea in a 78-Year-Old Female Patient
Annals of Internal Medicine: Clinical Cases, 2023 Pityriasis rosea (PR) is a papulosquamous dermatosis seen most commonly in children and young adults. Variants of PR occur in 1 in 5 cases and can significantly impact a patient's quality of life.
Evelyn Fagan +3 more
doaj +1 more source
Subsets of T lymphocytes in the lesional skin of pityriasis rosea [PDF]
Anais Brasileiros de Dermatologia: Background: Pityriasis rosea is a common papulosquamous disorder. However, its etiology and pathogenesis remain unclear. Objective: We investigate the types of inflammatory cells infiltrating the lesional skin of pityriasis rosea and demonstrate ...
Shuqin Wang +5 more
doaj +2 more sources
Atypical pityriasis rosea in a young Colombian woman. Case report
Case Reports, 2021 Introduction: Pityriasis rosea is an acute and self-limited exanthem first described by Gilbert in 1860. Its treatment is symptomatic, and although there is no conclusive evidence, it has been associated with the reactivation of the human herpesviruses ...
Julián Felipe Porras-Villamil +3 more
doaj +1 more source